Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Price

RCKTStock
$3.783.02%52W
Market Cap$414.95M
P/E
PEG Ratio
Div yield
Beta0.44

RCKT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.93%
Price vs S&P 500 (4W)9.37%
VGM Score60.82

RCKT Earnings Surprise History

Q2 25-0.59est. -0.53
Q3 25-0.45est. -0.50
Q4 25-0.38est. -0.42
Q1 26-0.42est. -0.45
Q2 26-0.38est. 0.27

RCKT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.65
3.65
3.65
3.65

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
RCKTRocket Pharmaceuticals, Inc. Common Stock
B$3.78
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Rocket Pharmaceuticals, Inc. Common Stock

Rocket Pharmaceuticals is a late-stage biopharmaceutical company developing gene therapies for rare pediatric genetic diseases. Its pipeline includes five programs targeting Danon Disease, Fanconi Anemia, Leukocyte Adhesion Deficiency, Pyruvate Kinase Deficiency, and Infantile Malignant Osteopetrosis.